iPSC-derived CAR-NK (Green Cross LabCell)

N/A

Report date: 2025/01/26 19:28:20

Base Information

Drug NameiPSC-derived CAR-NK (Green Cross LabCell)
Drug Alias NameCAR NK-cell therapy (Green Cross LabCell)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunostimulantsNatural killer cells stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGC Cell Corp
China Registration ClassN/A

Develop Information

Active CompaniesGC Cell Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A